Browsing Open Access by Subject "pancreatic adenocarcinoma; programmed death ligand; microsatellite instability"
Now showing items 1-1 of 1
-
Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer
(2018-11-07)Immune checkpoint blockade (ICB) with programmed cell death protein-1(PD-1)/programmed death ligand -1(PD-L1) antibodies has revolutionized the management of several cancers, especially non-small cell lung cancer, melanoma, ...